Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1830018rdf:typepubmed:Citationlld:pubmed
pubmed-article:1830018lifeskim:mentionsumls-concept:C0014175lld:lifeskim
pubmed-article:1830018lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:1830018lifeskim:mentionsumls-concept:C0227843lld:lifeskim
pubmed-article:1830018lifeskim:mentionsumls-concept:C0010961lld:lifeskim
pubmed-article:1830018lifeskim:mentionsumls-concept:C0056855lld:lifeskim
pubmed-article:1830018lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:1830018lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:1830018lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:1830018pubmed:issue2lld:pubmed
pubmed-article:1830018pubmed:dateCreated1991-8-22lld:pubmed
pubmed-article:1830018pubmed:abstractTextWe studied the endometrial structure and ultrastructure in serial biopsies from 16 patients with endometriosis treated with danazol (n = 9) or the combination cyproterone acetate plus ethinyl estradiol (n = 7) for 6 months. Biopsies were performed before and at 3 and 6 months of treatment. The material obtained was studied by light (LM), scanning (SEM) and transmission electron microscopy (TEM). A morphometric analysis was performed evaluating three morphometric and three stereologic indices. The results indicate that danazol had a progestational effect on endometrial glands and stroma, associated with a marked hypotrophy of the mucosa. The cyproterone acetate/ethinyl estradiol combination induced progressive atrophy of the endometrium with an increase in the stromal component and a reduction of glandular tissue.lld:pubmed
pubmed-article:1830018pubmed:languageenglld:pubmed
pubmed-article:1830018pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1830018pubmed:citationSubsetIMlld:pubmed
pubmed-article:1830018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1830018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1830018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1830018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1830018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1830018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1830018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1830018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1830018pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1830018pubmed:statusMEDLINElld:pubmed
pubmed-article:1830018pubmed:monthJullld:pubmed
pubmed-article:1830018pubmed:issn0301-2115lld:pubmed
pubmed-article:1830018pubmed:authorpubmed-author:FedeleLLlld:pubmed
pubmed-article:1830018pubmed:authorpubmed-author:MarchiniMMlld:pubmed
pubmed-article:1830018pubmed:authorpubmed-author:BianchiSSlld:pubmed
pubmed-article:1830018pubmed:authorpubmed-author:Di NolaGGlld:pubmed
pubmed-article:1830018pubmed:authorpubmed-author:BrioschiDDlld:pubmed
pubmed-article:1830018pubmed:authorpubmed-author:ArcainiLLlld:pubmed
pubmed-article:1830018pubmed:issnTypePrintlld:pubmed
pubmed-article:1830018pubmed:day1lld:pubmed
pubmed-article:1830018pubmed:volume40lld:pubmed
pubmed-article:1830018pubmed:ownerNLMlld:pubmed
pubmed-article:1830018pubmed:authorsCompleteYlld:pubmed
pubmed-article:1830018pubmed:pagination137-43lld:pubmed
pubmed-article:1830018pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:meshHeadingpubmed-meshheading:1830018-...lld:pubmed
pubmed-article:1830018pubmed:year1991lld:pubmed
pubmed-article:1830018pubmed:articleTitleEndometrial patterns during danazol and cyproterone acetate treatment for endometriosis: structural and ultrastructural study.lld:pubmed
pubmed-article:1830018pubmed:affiliation1st Department of Obstetrics and Gynecology, University of Milan, Italy.lld:pubmed
pubmed-article:1830018pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1830018pubmed:publicationTypeComparative Studylld:pubmed